Iwata H - Search Results

1

Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE.

Johnston SRD, Hegg R, Im SA, Park IH, Burdaeva O, Kurteva G, Press MF, Tjulandin S, Iwata H, Simon SD, Kenny S, Sarp S, Izquierdo MA, Williams LS, Gradishar WJ. Johnston SRD, et al. Among authors: iwata h. J Clin Oncol. 2021 Jan 1;39(1):79-89. doi: 10.1200/JCO.20.01894. Epub 2020 Aug 21. J Clin Oncol. 2021. PMID: 32822287 Clinical Trial.

2

Perspective of trastuzumab treatment.

Iwata H. Iwata H. Breast Cancer. 2007;14(2):150-5. doi: 10.2325/jbcs.955. Breast Cancer. 2007. PMID: 17485899 Free article. Review.

3

Dose-finding phase I and pharmacokinetic study of capecitabine (Xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer.

Saji S, Toi M, Morita S, Iwata H, Ito Y, Ohno S, Kobayashi T, Hozumi Y, Sakamoto J. Saji S, et al. Among authors: iwata h. Oncology. 2007;72(5-6):330-7. doi: 10.1159/000113062. Epub 2008 Jan 12. Oncology. 2007. PMID: 18187954 Clinical Trial.

4

A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment.

Hayashi H, Kimura M, Yoshimoto N, Tsuzuki M, Tsunoda N, Fujita T, Yamashita T, Iwata H. Hayashi H, et al. Among authors: iwata h. Breast Cancer. 2009;16(2):136-40. doi: 10.1007/s12282-008-0060-1. Epub 2008 Jun 12. Breast Cancer. 2009. PMID: 18548321

5

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan.

Tokudome N, Ito Y, Hatake K, Toi M, Sano M, Iwata H, Sato Y, Saeki T, Aogi K, Takashima S. Tokudome N, et al. Among authors: iwata h. Anticancer Drugs. 2008 Aug;19(7):753-9. doi: 10.1097/CAD.0b013e328302eb15. Anticancer Drugs. 2008. PMID: 18594220 Clinical Trial.

6

Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.

Watanabe T, Sano M, Takashima S, Kitaya T, Tokuda Y, Yoshimoto M, Kohno N, Nakagami K, Iwata H, Shimozuma K, Sonoo H, Tsuda H, Sakamoto G, Ohashi Y. Watanabe T, et al. Among authors: iwata h. J Clin Oncol. 2009 Mar 20;27(9):1368-74. doi: 10.1200/JCO.2008.18.3939. Epub 2009 Feb 9. J Clin Oncol. 2009. PMID: 19204202 Clinical Trial.

7

Phase II study of preoperative systemic treatment with the combination of docetaxel and trastuzumab in patients with locally advanced HER-2-overexpressing breast cancer.

Sawaki M, Iwata H, Sato Y, Wada M, Toyama T, Sasaki E, Yatabe Y, Imai T, Ohashi Y. Sawaki M, et al. Among authors: iwata h. Breast. 2010 Oct;19(5):370-6. doi: 10.1016/j.breast.2010.03.021. Epub 2010 May 15. Breast. 2010. PMID: 20472435 Free article. Clinical Trial.

8

Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept.

Iwata H. Iwata H. Breast Cancer. 2011 Apr;18(2):92-7. doi: 10.1007/s12282-010-0233-6. Epub 2010 Dec 8. Breast Cancer. 2011. PMID: 21140250 Review.

9

Evaluation of trastuzumab without chemotherapy as a post-operative adjuvant therapy in HER2-positive elderly breast cancer patients: randomized controlled trial [RESPECT (N-SAS BC07)].

Sawaki M, Tokudome N, Mizuno T, Nakayama T, Taira N, Bando H, Murakami S, Yamamoto Y, Kashiwaba M, Iwata H, Uemura Y, Ohashi Y. Sawaki M, et al. Among authors: iwata h. Jpn J Clin Oncol. 2011 May;41(5):709-12. doi: 10.1093/jjco/hyr011. Epub 2011 Feb 24. Jpn J Clin Oncol. 2011. PMID: 21355003 Clinical Trial.

10

High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers.

Horio A, Fujita T, Hayashi H, Hattori M, Kondou N, Yamada M, Adachi E, Ushio A, Gondou N, Sueta A, Yatabe Y, Iwata H. Horio A, et al. Among authors: iwata h. Int J Clin Oncol. 2012 Apr;17(2):131-6. doi: 10.1007/s10147-011-0269-4. Epub 2011 Jun 18. Int J Clin Oncol. 2012. PMID: 21681642 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,980 results

Search Page